Kenosha AI develops an artificial intelligence platform specifically for the clinical research industry, utilizing enterprise-grade AI to enhance operational efficiency and decision-making. The platform significantly reduces the time and resources required for tasks such as Informed Consent Form writing and regulatory inquiries, enabling faster clinical trial timelines and improved access to life-saving treatments.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The clinical research industry faces challenges in operational efficiency, particularly in tasks such as Informed Consent Form (ICF) writing and navigating complex regulatory inquiries. These inefficiencies can lead to slower clinical trial timelines and delays in accessing life-saving treatments.
Solution
Kenosha AI offers an AI platform designed to streamline clinical research operations and enhance decision-making. The platform leverages enterprise-grade AI to significantly reduce the time and resources required for critical tasks. By automating and accelerating processes like ICF writing and regulatory research, Kenosha AI aims to improve productivity, shorten clinical trial timelines, and ultimately expedite the delivery of new treatments to patients. The platform includes AI copilots and custom GPTs that enable users to interact with enterprise documents and receive rapid, well-informed answers to regulatory questions.
Target Audience
Kenosha AI targets professionals in the clinical research industry, including those at CROs, pharmaceutical companies, and research institutions, who seek to improve operational efficiency and accelerate clinical trial timelines.
Features
- Informed Consent Form (ICF) Copilot: Automates ICF writing, increasing margin on ICF writing services.
- Proposal & Budget Copilot: Reduces workload in responding to RFIs and RFPs.
- Custom Enterprise GPTs: Connects enterprise documents with AI for conversational chat and rapid answers.
- RegChat™: Provides up-to-date, source-linked summarizations and comparisons across multiple regulatory agencies.
- Access to regulatory guidance using AI and official regulatory guidance documents for reference.
- GPT-4 powered responses that search guidance documents for relevant information.